Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”

Detalles Bibliográficos
Autores principales: Putzke, Joerg, Haughie, Scott, Zou, Kelly H., Ranganna, Gopinath M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084790/
https://www.ncbi.nlm.nih.gov/pubmed/33860919
http://dx.doi.org/10.1007/s40259-021-00476-9
_version_ 1783686225497948160
author Putzke, Joerg
Haughie, Scott
Zou, Kelly H.
Ranganna, Gopinath M.
author_facet Putzke, Joerg
Haughie, Scott
Zou, Kelly H.
Ranganna, Gopinath M.
author_sort Putzke, Joerg
collection PubMed
description
format Online
Article
Text
id pubmed-8084790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80847902021-05-05 Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database” Putzke, Joerg Haughie, Scott Zou, Kelly H. Ranganna, Gopinath M. BioDrugs Letter to the Editor Springer International Publishing 2021-04-16 2021 /pmc/articles/PMC8084790/ /pubmed/33860919 http://dx.doi.org/10.1007/s40259-021-00476-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter to the Editor
Putzke, Joerg
Haughie, Scott
Zou, Kelly H.
Ranganna, Gopinath M.
Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title_full Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title_fullStr Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title_full_unstemmed Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title_short Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
title_sort comment on: “safety of marketed cancer supportive care biosimilars in the u.s.: a disproportionality analysis using the food and drug administration adverse event reporting system (faers) database”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084790/
https://www.ncbi.nlm.nih.gov/pubmed/33860919
http://dx.doi.org/10.1007/s40259-021-00476-9
work_keys_str_mv AT putzkejoerg commentonsafetyofmarketedcancersupportivecarebiosimilarsintheusadisproportionalityanalysisusingthefoodanddrugadministrationadverseeventreportingsystemfaersdatabase
AT haughiescott commentonsafetyofmarketedcancersupportivecarebiosimilarsintheusadisproportionalityanalysisusingthefoodanddrugadministrationadverseeventreportingsystemfaersdatabase
AT zoukellyh commentonsafetyofmarketedcancersupportivecarebiosimilarsintheusadisproportionalityanalysisusingthefoodanddrugadministrationadverseeventreportingsystemfaersdatabase
AT rangannagopinathm commentonsafetyofmarketedcancersupportivecarebiosimilarsintheusadisproportionalityanalysisusingthefoodanddrugadministrationadverseeventreportingsystemfaersdatabase

Ejemplares similares